Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
A vaccine developed by the Danish company Bavarian Nordic has received FDA approval to prevent…
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase…
A test for sepsis developed by the Swiss diagnostics company Abionic was able to predict…
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first…
A vaccine targeting the sexually transmitted infection chlamydia, which would be the first of its…
Each day more than one million people around the world acquire sexually transmitted infections, with…
We spend a lot of time focusing on specific developments in biotechnology, but sometimes it's…
We are visiting the medieval German city of Tübingen this week. It hosts the biotech…
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
A European academic research collaboration has found a new potential weapon against antibiotic-resistant tuberculosis: its…